Olaparib Monotherapy Yields Good PSA Response Rates in Prostate Cancer
Response rates seen in patients with high-risk biochemically recurrent prostate cancer after radical prostatectomy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.